Neurokinin 3 receptor antagonists for treatment of vasomotor symptoms: a new panacea or just a flash in the pan?
Menopause
.
2018 Aug;25(8):859-861.
doi: 10.1097/GME.0000000000001144.
Authors
Stephanie S Faubion
1
,
Cynthia A Stuenkel
Affiliation
1
Women's Health Clinic, Division of General and Internal Medicine, Mayo Clinic, Rochester, MN Department of Endocrinology and Metabolism, University of California, San Diego, La Jolla, CA.
PMID:
29870472
DOI:
10.1097/GME.0000000000001144
No abstract available
Publication types
Editorial
Comment
MeSH terms
Receptors, Neurokinin-3 / antagonists & inhibitors*
Substances
Receptors, Neurokinin-3
Grants and funding
MR/M024954/1/MRC_/Medical Research Council/United Kingdom